乳房再造医生支付趋势
研究基于Blue Health Intelligence数据库2009至2013年数据,分析乳房再造手术发生率与医生支付趋势。组织扩张器病例发生率显著上升(发生率比1.09,p<0.001),游离皮瓣病例发生率无变化(发生率比1.02,p=0.222)。组织扩张器调整后平均支付总额增长6.5%(从2232美元至2378美元),游离皮瓣为-1.8%(从3858美元至3788美元)。
要点
- 组织扩张器病例发生率显著上升(发生率比1.09,p<0.001),游离皮瓣无变化(发生率比1.02,p=0.222)。
- 组织扩张器平均支付增长6.5%(2232至2378美元),游离皮瓣为-1.8%(3858至3788美元)。
- 游离皮瓣支付变异更大(四分位距2243美元 vs 组织扩张器987美元)。
核心结论
- 组织扩张器病例发生率和支付在研究期间上升,而游离皮瓣病例发生率和支付持平。
- 游离皮瓣停滞的原因尚不清楚,但施行该手术的机会成本可能激励替代技术。
- 自体再造支付变异更大,提示与支付方协商的机会。
研究设计与样本
- 查询Blue Health Intelligence数据库2009至2013年数据,识别有乳房再造索赔的女性。
- 使用回归模型按方法和年份描述手术发生率和医生支付趋势。
- 共纳入21259例乳房再造病例。
主要发现
- 组织扩张器病例发生率显著上升(发生率比1.09;p<0.001),游离皮瓣病例发生率无变化(发生率比1.02;p=0.222)。
- 双侧组织扩张器病例支付为单侧的1.32倍,双侧游离皮瓣支付为单侧的1.61倍。
- 组织扩张器调整后平均支付总额增长6.5%(从2232美元至2378美元),游离皮瓣为-1.8%(从3858美元至3788美元)。
- 线性模型显示仅组织扩张器支付显著增加。
- 游离皮瓣的医生支付变异更大(第25至75百分位四分位距为2243美元 vs 组织扩张器987美元)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prosthetic breast reconstruction rates have risen in the United States, whereas autologous techniques have stagnated. Meanwhile, single-institution data demonstrate that physician payments for prosthetic reconstruction are rising, while payments for autologous techniques are unchanged. This study aims to assess payment trends and variation for tissue expander and free flap breast reconstruction. METHODS: The Blue Health Intelligence database was queried from 2009 to 2013, identifying women with claims for breast reconstruction. Trends in the incidence of surgery and physician reimbursement were characterized by method and year using regression models. RESULTS: There were 21,259 episodes of breast reconstruction, with a significant rise in tissue expander cases (incidence rate ratio, 1.09; p < 0.001) and an unchanged incidence of free flap cases (incidence rate ratio, 1.02; p = 0.222). Bilateral tissue expander cases reimbursed 1.32 times more than unilateral tissue expanders, whereas bilateral free flaps reimbursed 1.61 times more than unilateral variants. The total growth in adjusted tissue expander mean payments was 6.5 percent (from $2232 to $2378) compared with -1.8 percent (from $3858 to $3788) for free flaps. Linear modeling showed significant increases for tissue expander reimbursements only. Surgeon payments varied more for free flaps (the 25th to 75th percentile interquartile range was $2243 for free flaps versus $987 for tissue expanders). CONCLUSIONS: The incidence of tissue expander cases and reimbursements rose over a period where the incidence of free flap cases and reimbursements plateaued. Reasons for stagnation in free flaps are unclear; however, the opportunity cost of performing this procedure may incentivize the alternative technique. Greater payment variation in autologous reconstruction suggests the opportunity for negotiation with payers.
引用
- Sheckter CC, Yi D, Panchal HJ, et al. Trends in Physician Payments for Breast Reconstruction. Plast Reconstr Surg. 2018. PMID: 29595721. doi:10.1097/PRS.0000000000004205
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。